Kristen Ambrose, SVP & Chief Accounting Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 1,968 shares at $460.43 ($911K) on 2026-02-11, disclosed to the SEC on 2026-02-12.
Scheduled sale ($911k) by SVP & Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $468.41 | 592 | $277K | 30.4% |
| 2 | $460.43 | 1,376 | $634K | 69.6% |
| Total | $462.83 avg | 1,968 | $911K | 100% |
| Filing → |
| VRTX | SELL | 2026-02-19 | $1.1M | — | Filing → |
| VRTX | SELL | 2025-02-26 | $850K | — | Filing → |
| VRTX | SELL | 2025-02-19 | $611K | — | Filing → |